|
So. San Francisco, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Monogram
Biosciences, Inc. (Nasdaq: MGRM) announced today that William D. Young, CEO
and Chairman, is scheduled to present a corporate overview at the Lazard
Capital Markets 2005 Life Sciences Conference on Tuesday, November 29, 2005 at
2:30 p.m. Eastern Time at the Palace Hotel in New York City.
To access the live audio broadcast or the subsequent archived recording
log on to http://www.monogrambio.com/ and go to the investor relations section
to the link provided on the Event Calendar page. The archived version of the
webcast will be available online for one month.
About Monogram Biosciences, Inc.
Monogram, formerly ViroLogic, Inc., is advancing individualized medicine
by discovering, developing and marketing innovative products to guide and
improve treatment of serious infectious diseases and cancer. The Companys
products are designed to help doctors optimize treatment regimens for their
patients that lead to better outcomes and reduced costs. The Companys
technology is also being used by numerous biopharmaceutical companies to
develop new and improved antiviral therapeutics and vaccines as well as
targeted cancer therapeutics. More information about the Company and its
technology can be found on its web site at http://www.monogrambio.com.
|
|
